Overall rank by patents
#40,595
Across all tracked assignees
USPTO PatentsView assignee record - 6 granted patents across 3 technology areas, active 2024–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G16C (COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE).
The verdict
Hangzhou holds 6 US patents across 3 technology areas, rank #40,595 of 50,000 tracked assignees.
Hangzhou Fujia Gallium Technology Co. Ltd. has been granted 6 US utility patents between 2024 and 2024, placing Hangzhou Fujia Gallium Technology Co. Ltd. at rank #40,595 across all assignees tracked by PlainPatent. This portfolio spans 3 distinct Cooperative Patent Classification (CPC) subclasses, averaging 10.0 claims per patent with primary concentration in G16C (COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE). As a Foreign Corporation, Hangzhou Fujia Gallium Technology Co. Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Hangzhou sits between HAN Sheng Biotech Co., Ltd. (6 patents, rank #40,591) and Hangzhou Ole-systems Co., Ltd. (6 patents, rank #40,599) - the closest US assignees by grant volume. The composite Innovation Score of 38.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2024 through 2024, with 6 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Hangzhou Fujia Gallium Technology Co. Ltd.'s 10.0 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while specialization in 3 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Hangzhou Fujia Gallium Technology Co. Ltd. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
HAN SHENG BIOTECH CO., LTD.
6 patents
HANA TECHNOLOGY CO., LTD.
6 patents
HANCOCK MEDICAL, INC.
6 patents
HANGZHOU CANAAN INTELLIGENCE INFORMATION TECHNOLOGY CO., LTD
6 patents
HANGZHOU JINGCHENG SANHE TIMER INDUSTRY CO., LTD.
6 patents
HANGZHOU LEADERWAY ELECTRONICS CO., LTD
6 patents
HANGZHOU LHD INSTITUTE OF NEW ENERGY, LLC
6 patents
HANGZHOU OLE-SYSTEMS CO., LTD.
6 patents
HANGZHOU FUJIA GALLIUM TECHNOLOGY CO. LTD.
6 patents
What this shows Hangzhou holds 6 patents at rank #40,595, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #40,595 in granted patent volume.
Other assignees with the most granted patents in Hangzhou's primary technology class.
Hangzhou's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
39 Top 40% higher than 60% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2024–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2024 | 6 | 100.0% |
Top 3 of 3 technology areas
Overall rank by patents
#40,595
Across all tracked assignees
38.9 out of 100
How to use this portfolio
Hangzhou's 6 grants land it in the top 40% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.